Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jolivet

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenograftsS Weitman, J Marty, J Jolivet, et al.
Stem Cells (Dayton, Ohio)|January 1, 1996
Biochemical and molecular studies of human methenyltetrahydrofolate synthetaseJ Jolivet, A Dayan, M Beauchemin, et al.
Cancer Treatment Reports|November 1, 1979
Tamoxifen-induced tumor stimulation and withdrawal responseS Legault-Poisson, J Jolivet, R Poisson, et al.
Cancer|February 15, 1997
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trialJ D Hainsworth, J Jolivet, R Birch, et al.
Cancer Treatment Reports|May 1, 1983
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndromeJ Jolivet, L Giroux, S Laurin, et al.
Biochemical Pharmacology|February 11, 1994
Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexateJ Jolivet, G Jansen, G J Peters, et al.
British Journal of Cancer|January 1, 1997
Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cellsJ Jolivet, M P Faure, S C Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials GroupW C Mertens, E A Eisenhauer, J Jolivet, et al.
The Journal of Clinical Investigation|August 1, 1982
Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cellsJ Jolivet, R L Schilsky, B D Bailey, et al.
The New England Journal of Medicine|November 3, 1983
The pharmacology and clinical use of methotrexateJ Jolivet, K H Cowan, G A Curt, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenograftsS Weitman, J Marty, J Jolivet, et al.
Stem Cells (Dayton, Ohio)|January 1, 1996
Biochemical and molecular studies of human methenyltetrahydrofolate synthetaseJ Jolivet, A Dayan, M Beauchemin, et al.
Cancer Treatment Reports|November 1, 1979
Tamoxifen-induced tumor stimulation and withdrawal responseS Legault-Poisson, J Jolivet, R Poisson, et al.
Cancer|February 15, 1997
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trialJ D Hainsworth, J Jolivet, R Birch, et al.
Cancer Treatment Reports|May 1, 1983
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndromeJ Jolivet, L Giroux, S Laurin, et al.
Biochemical Pharmacology|February 11, 1994
Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexateJ Jolivet, G Jansen, G J Peters, et al.
British Journal of Cancer|January 1, 1997
Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cellsJ Jolivet, M P Faure, S C Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials GroupW C Mertens, E A Eisenhauer, J Jolivet, et al.
The Journal of Clinical Investigation|August 1, 1982
Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cellsJ Jolivet, R L Schilsky, B D Bailey, et al.
The New England Journal of Medicine|November 3, 1983
The pharmacology and clinical use of methotrexateJ Jolivet, K H Cowan, G A Curt, et al.
Pageof 7